与癌症相关的纤维细胞:在甲状腺瘤进展和治疗中的"阿基里斯脚跟"
Xiaoxiao Li1, Hengtong Han2, Shouhua Li1
1The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Cellular signalling
|November 7, 2025
概括
与癌症相关的纤维细胞 (CAF) 通过与瘤微环境相互作用,驱动甲状腺癌 (TC) 的进展和治疗耐药性. 针对CAF提供了一个有希望的治疗策略,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 显著影响癌症的发展和治疗疗效.
- 癌症相关纤维细胞 (CAFs) 是TME中的关键肌层细胞,与瘤进展和治疗耐药性有关.
研究的目的:
- 在甲状腺癌 (TC) 中审查了解癌症相关纤维细胞 (CAFs) 的最新进展.
- 探索TC中CAF的起源,异质性和功能.
- 总结CAF介导的瘤进展和治疗耐药性的机制,并评估向策略.
主要方法:
- 关于甲状腺癌中CAFs最近研究的文献综述.
- 对CAF起源,表型和功能异质性的分析.
- 检查CAF与TME内的瘤和免疫细胞的相互作用.
主要成果:
- CAFs是异质的和塑性,显著影响TC进展和抵抗.
- CAFs重塑细胞外基质,影响瘤细胞的行为和免疫反应.
- CAFs和其他TME组件之间的双向相互作用驱动恶性瘤.
结论:
- 对TC中CAF的全面理解对于开发有效疗法至关重要.
- 向CAFs为改善甲状腺癌治疗结果提供了一个有希望的途径.
- 未来的研究应该专注于进一步阐明CAF生物学和治疗策略.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Introduction to Fibroblasts
3.8K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.8K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K


